Teva Loses Challenge Of €60M Pay-For-Delay Fine
By Matthew Perlman · October 18, 2023, 7:10 PM EDT
A European court on Wednesday rejected an appeal from Teva and its subsidiary Cephalon seeking to nix more than €60 million ($63.2 million) in fines for allegedly conspiring with one another...
To view the full article, register now.